3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
16
Colorectal Neoplasms
14
Neoplasms
12
Hematopoietic and Lymphatic System Neoplasm
12
Lung Neoplasms
9
Hematologic Neoplasms
8
Ovarian Neoplasms
5
Multiple Myeloma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Malignant Solid Neoplasm
4
Lymphoma
4
Urinary Bladder Neoplasms
3
Hematopoietic and Lymphoid System Neoplasm
3
Endometrial Neoplasms
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Mouth Neoplasms
2
Motor Activity
2
Melanoma
2
Malignant Female Reproductive System Neoplasm
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Interventions
Nivolumab
11
pembrolizumab
10
Ipilimumab
9
Cyclophosphamide
6
tebentafusp
5
Interleukin-2
4
Blood Specimen Collection
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
relatlimab
2
lenvatinib
2
cemiplimab
2
binimetinib
2
aflibercept
2
Surveys and Questionnaires
2
Dacarbazine
2
Crizotinib
2
Carmustine
2
Biopsy
2
ulixertinib
1
trametinib
1
sargramostim
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Interviews as Topic
×
1 year
×
Clear all
No trials found.